Multifactorial aspects of antibody-mediated blood cell destruction

作者: R. Kapur

DOI:

关键词: Neonatal alloimmune thrombocytopeniaAntibody titerImmune systemImmunologyFetusPlateletPregnancyAntibodyBlood cellMedicine

摘要: The research described in this thesis focuses on diseases of antibody-mediated blood cell destruction via FcγRs phagocytes, particular regarding platelets fetal or neonatal alloimmune thrombocytopenia (FNAIT) and red cells (RBC) hemolytic disease the fetus newborn (HDFN). Diagnostically, for HDFN laboratory tests are place order to predict risk severe RBC thereby initiate appropriate treatments. This test is sensitive, but has relatively low specificity. For FNAIT, no diagnostic currently available platelet destruction. FNAIT it been suggested that decrease numbers determined by antibody titer, correlation does not appear be strict. indicates other factors, besides antibody-titer involved as such C-reactive protein (CRP) anti-platelet IgG-fucosylation identified. CRP, which bound after platelet-oxidation, enhanced both vitro vivo was found elevated immune thrombocytopenic patients. CRP levels dropped IVIg-treatment, accompanied normalization counts decreased clinical bleeding severity. A Fc-fucosylation observed anti- antibodies (and total IgG), resulted increased binding affinity FcγRIIIa/b, phagocytosis, correlated with also an adverse scenario. data need validated larger patient cohorts, monitoring promising potential. lowered anti-RBC (anti-D) pregnancy, hemolysis a small pilot-study, however more needed. anti-D Fc-fucose occurred male hyperimmunized donors (although lesser extent than pregnant women), indicating regulation fucosylation strictly dependent upon pregnancy setting. implications antibody-fucosylation immunoprophylaxis, derived from donors, discussed.

参考文章(110)
Kathryn L Armour, David R Parry-Jones, Nigel Beharry, James R Ballinger, Rosey Mushens, R Keith Williams, Cynthia Beatty, Simon Stanworth, Paul Lloyd-Evans, Marion Scott, Michael R Clark, A Michael Peters, Lorna M Williamson, None, Intravascular survival of red cells coated with a mutated human anti-D antibody engineered to lack destructive activity. Blood. ,vol. 107, pp. 2619- 2626 ,(2006) , 10.1182/BLOOD-2005-03-0989
Françoise A. Gala, Sherie L. Morrison, V region carbohydrate and antibody expression. Journal of Immunology. ,vol. 172, pp. 5489- 5494 ,(2004) , 10.4049/JIMMUNOL.172.9.5489
M. K. Killie, A. Husebekk, J. Kjeldsen-Kragh, B. Skogen, A prospective study of maternal anti-HPA 1a antibody level as a potential predictor of alloimmune thrombocytopenia in the newborn Haematologica. ,vol. 93, pp. 870- 877 ,(2008) , 10.3324/HAEMATOL.12515
Maja Pučić Baković, Maurice H. J. Selman, Marcus Hoffmann, Igor Rudan, Harry Campbell, André M. Deelder, Gordan Lauc, Manfred Wuhrer, High-Throughput IgG Fc N-Glycosylation Profiling by Mass Spectrometry of Glycopeptides Journal of Proteome Research. ,vol. 12, pp. 821- 831 ,(2013) , 10.1021/PR300887Z
Teemu T. Junttila, Kathryn Parsons, Christine Olsson, Yanmei Lu, Yan Xin, Julie Theriault, Lisa Crocker, Oliver Pabonan, Tomasz Baginski, Gloria Meng, Klara Totpal, Robert F. Kelley, Mark X. Sliwkowski, Superior In vivo Efficacy of Afucosylated Trastuzumab in the Treatment of HER2-Amplified Breast Cancer Cancer Research. ,vol. 70, pp. 4481- 4489 ,(2010) , 10.1158/0008-5472.CAN-09-3704
R. Saldova, L. Royle, C. M Radcliffe, U. M Abd Hamid, R. Evans, J. N Arnold, R. E Banks, R. Hutson, D. J Harvey, R. Antrobus, S. M Petrescu, R. A Dwek, P. M Rudd, Ovarian Cancer is Associated With Changes in Glycosylation in Both Acute-Phase Proteins and IgG Glycobiology. ,vol. 17, pp. 1344- 1356 ,(2007) , 10.1093/GLYCOB/CWM100
Sylvia Miescher, Martin O. Spycher, Hanspeter Amstutz, Masja de Haas, Marion Kleijer, Ulrich J. Kalus, Hartmut Radtke, Alphonse Hubsch, Irmgard Andresen, Roland M. Martin, Johann Bichler, A single recombinant anti-RhD IgG prevents RhD immunization: association of RhD-positive red blood cell clearance rate with polymorphisms in the FcγRIIA and FcγIIIA genes Blood. ,vol. 103, pp. 4028- 4035 ,(2004) , 10.1182/BLOOD-2003-11-3929
Shigeru Iida, Reiko Kuni-Kamochi, Katsuhiro Mori, Hirofumi Misaka, Miho Inoue, Akira Okazaki, Kenya Shitara, Mitsuo Satoh, Two mechanisms of the enhanced antibody-dependent cellular cytotoxicity (ADCC) efficacy of non-fucosylated therapeutic antibodies in human blood BMC Cancer. ,vol. 9, pp. 58- 58 ,(2009) , 10.1186/1471-2407-9-58
Takuji Yamao, Tetsuya Noguchi, Osamu Takeuchi, Uichi Nishiyama, Haruhiko Morita, Tetsuya Hagiwara, Hironori Akahori, Takashi Kato, Kenjiro Inagaki, Hideki Okazawa, Yoshitake Hayashi, Takashi Matozaki, Kiyoshi Takeda, Shizuo Akira, Masato Kasuga, Negative regulation of platelet clearance and of the macrophage phagocytic response by the transmembrane glycoprotein SHPS-1. Journal of Biological Chemistry. ,vol. 277, pp. 39833- 39839 ,(2002) , 10.1074/JBC.M203287200
B. M. KUMPEL, M. DE HAAS, H. R. KOENE, J. G. J. VAN DE WINKEL, M. J. GOODRICK, Clearance of red cells by monoclonal IgG3 anti-D in vivo is affected by the VF polymorphism of Fc gamma RIIIa (CD16) Clinical and Experimental Immunology. ,vol. 132, pp. 81- 86 ,(2003) , 10.1046/J.1365-2249.2003.02119.X